Eli Lilly and Company en las noticias
Desarrollo de medicamentos para las necesidades
Tamtam encontró 20 artículos recientes sobre Eli Lilly and Company.
- Transcript: Eli Lilly Q2 2026 Earnings Conference Call
- If You Invested $1000 in Eli Lilly a Decade Ago, This is How Much It'd Be Worth Now
- Eli Lilly (LLY) Has a Powerful Growth Flywheel Beyond Its GLP-1 Success
- Eli Lilly and the LA Dodgers: A tale of 2 dynasties
- Eli Lilly sued over stomach problems patient ties to Mounjaro and Trulicity
- Eli Lilly Quietly Expands Its Alzheimer’s Pipeline With New Early-Stage Trial
- Eli Lilly: Buy The GLP-1 Growth Premium
- Eli Lilly: Impressive Growth, Questionable Valuation (NYSE:LLY)
- This Small-Cap Stock Announced a Deal With Eli Lilly. Then Its Shares Doubled
- Eli Lilly and vs. Novo Nordisk A/S: Which Healthcare Stock Is a Better Buy in 2026?
- Eli Lilly Has Been a Growth Beast, but This Is the Riskiest Part About Its Stock
- Eli Lilly Stock (LLY) Gains on Regulatory Win for Experimental Cancer Drug
- Eli Lilly vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?
- Lilly doubles down on Gate alliance to unlock new drug class with another $870M+ in biobucks
- Eli Lilly Just Announced Something Big. Here’s What It Means for Investors.
- Lilly signals move into aesthetics, looking to add products for body, skin and hair
- Prediction: Eli Lilly Could Be the Next $2 Trillion Drugmaker
- Katwijk approves permits for $3 billion Eli Lilly pharmaceutical plant
- Lilly bypasses Australian pharmacies with DTC model
- How Eli Lilly Just Extended Its Lead in the Weight-Loss Drug Market
Artículos recopilados por Tamtam y conservados cuando tratan sobre la empresa, del más reciente al más antiguo. Cada uno enlaza con su fuente.
¿Vendes a empresas como Eli Lilly and Company?
Tamtam encuentra las empresas que encajan con tu cliente ideal, investiga cada cuenta y te dice a quién contactar y cuándo.
Encontrar empresas similares